C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/29 (2006.01) A61K 39/295 (2006.01) A61P 31/14 (2006.01) C07K 14/18 (2006.01) C12N 15/51 (2006.01)
Patent
CA 2505611
The invention provides a method of activating hepatitis C virus (HCV)-specific T cells, including CD4+ and CD8+ T cells. HCV-specific T cells are activated using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins, or polypeptide or polynucleotide compositions containing the individual components of these fusions. The method can be used in model systems to develop HCV-specific immunogenic compositions, as well as to immunize a mammal against HCV.
L'invention concerne un procédé d'activation de lymphocytes T spécifiques du virus de l'hépatite C (VHC), notamment des lymphocytes T CD4?+¿ et CD8?+¿. Les lymphocytes T spécifiques du VHC sont activés au moyen de protéines de fusion comprenant des polypeptides du VHC NS3, NS4, NS5a, et NS5b, des polynucléotides codant lesdites protéines de fusion, ou des compositions polypeptidiques ou polynucléotidiques contenant les composants individuels de ces fusions. Le procédé de l'invention peut être utilisé dans des systèmes modèles pour développer des compositions immunogènes spécifiques du VHC, ainsi que pour immuniser un mammifère contre le VHC.
Coates Steve
Houghton Michael
Paliard Xavier
Selby Mark
Borden Ladner Gervais Llp
Chiron Corporation
Novartis Vaccines And Diagnostics Inc.
LandOfFree
Activation of hcv-specific cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activation of hcv-specific cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activation of hcv-specific cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1848687